Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Ritchlin · SciRah

Researcher profile · Semantic Scholar

C. Ritchlin

Share profile

C. Ritchlin — researcher profile on SciRah

h-index: 69
Works: 374
Citations: 20K

Most-cited papers

Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial.
I. McInnes, F. Behrens, P. Mease, A. Kavanaugh +11 more
2020The Lancet242 citations Open access
Semantic Scholar
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE).
J. Merola, R. Landewé, I. McInnes, P. Mease +15 more
2022The Lancet130 citations Open access
Semantic Scholar
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL).
I. McInnes, A. Asahina, L. Coates, R. Landewé +12 more
2022The Lancet129 citations Open access
Semantic Scholar
Axial spondyloarthritis: new advances in diagnosis and management
C. Ritchlin, I. Adamopoulos
2021British medical journal121 citations
Semantic Scholar
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments
J. Gelfand, A. Armstrong, S. Bell, G. Anesi +23 more
2021Journal of American Academy of Dermatology83 citations Open access
Semantic Scholar
Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced
C. Ritchlin, P. Helliwell, W. Boehncke, E. Soriano +15 more
2021RMD Open66 citations Open access
Semantic Scholar
Does biologic therapy impact the development of PsA among patients with psoriasis?
Elana A. Meer, J. Merola, R. Fitzsimmons, T. Love +10 more
2021Annals of the Rheumatic Diseases63 citations
Semantic Scholar
Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis
P. Mease, I. McInnes, Lai-Shan Tam, K. Eaton +8 more
2021Rheumatology58 citations Open access
Semantic Scholar
Consensus terminology for preclinical phases of psoriatic arthritis for use in research studies: results from a Delphi consensus study
L. Perez-Chada, R. Haberman, V. Chandran, C. Rosen +7 more
2021Nature Reviews Rheumatology49 citations Open access
Semantic Scholar
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1
J. Gelfand, A. Armstrong, S. Bell, G. Anesi +24 more
2020Journal of American Academy of Dermatology49 citations Open access
Semantic Scholar
Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study
C. Ritchlin, L. Coates, I. McInnes, P. Mease +11 more
2023Annals of the Rheumatic Diseases47 citations Open access
Semantic Scholar
New Frontiers in Psoriatic Disease Research, Part I: Genetics, Environmental Triggers, Immunology, Pathophysiology, and Precision Medicine
Di Yan, J. Gudjonsson, S. Le, E. Maverakis +7 more
2021Journal of Investigative Dermatology47 citations Open access
Semantic Scholar
Mapping the dynamic genetic regulatory architecture of HLA genes at single-cell resolution
Joyce B. Kang, Amber Z. Shen, Saisriram Gurajala, A. Nathan +101 more
2023Nature Genetics43 citations Open access
Semantic Scholar
Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety.
Frank Kolbinger, F. D. di Padova, A. Deodhar, J. Hawkes +12 more
2021Pharmacology and Therapeutics41 citations Open access
Semantic Scholar
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL
L. Coates, R. Landewé, I. McInnes, P. Mease +14 more
2024RMD Open38 citations Open access
Semantic Scholar
Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis
J. Giles, A. Ogdie, J. Gómez-Reino, P. Helliwell +7 more
2021RMD Open36 citations Open access
Semantic Scholar
Safety and Efficacy of Bimekizumab in Patients With Active Psoriatic Arthritis: Three‐Year Results From a Phase IIb Randomized Controlled Trial and Its Open‐Label Extension Study
L. Coates, I. McInnes, J. Merola, R. Warren +8 more
2022Arthritis & Rheumatology33 citations Open access
Semantic Scholar
Crossing the boundaries: IL-23 and its role in linking inflammation of the skin, gut and joints
Z. Łukasik, Eric Gracey, K. Venken, C. Ritchlin +1 more
2021Rheumatology30 citations Open access
Semantic Scholar
Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic Arthritis
P. Rahman, C. Ritchlin, P. Helliwell, W. Boehncke +13 more
2021Journal of Rheumatology29 citations Open access
Semantic Scholar
Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies
D. McGonagle, I. McInnes, A. Deodhar, G. Schett +12 more
2021Rheumatology27 citations Open access
Semantic Scholar
Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritis
E. Pournara, Matthias Kormaksson, P. Nash, C. Ritchlin +7 more
2021RMD Open25 citations Open access
Semantic Scholar
Vaccination Recommendations for Adults Receiving Biologics and Oral Therapies for Psoriasis and Psoriatic Arthritis: Delphi Consensus from the Medical Board of the National Psoriasis Foundation.
V. Chat, C. Ellebrecht, Paige Kingston, Stacie Bell +31 more
2024Journal of American Academy of Dermatology22 citations
Semantic Scholar
Single-cell transcriptomics of popliteal lymphatic vessels and peripheral veins reveals altered lymphatic muscle and immune cell populations in the TNF-Tg arthritis model
H. Kenney, Chia-Lung Wu, A. Loiselle, L. Xing +2 more
2022Arthritis Research & Therapy22 citations Open access
Semantic Scholar
Differences in oxylipin profile in psoriasis versus psoriatic arthritis
R. Coras, A. Kavanaugh, Angela Kluzniak, D. Holt +5 more
2021Arthritis Research & Therapy21 citations Open access
Semantic Scholar
Ex vivo Demonstration of Functional Deficiencies in Popliteal Lymphatic Vessels From TNF-Transgenic Mice With Inflammatory Arthritis
Joshua P. Scallan, E. Bouta, Homaira Rahimi, H. Kenney +3 more
2021Frontiers in Physiology21 citations Open access
Semantic Scholar
Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies
C. Ritchlin, P. Mease, W. Boehncke, J. Tesser +12 more
2022RMD Open20 citations Open access
Semantic Scholar
Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritis
P. Nash, P. Richette, L. Gossec, A. Marchesoni +8 more
2021Rheumatology20 citations Open access
Semantic Scholar
Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase II Trial
P. Helliwell, A. Deodhar, A. Gottlieb, W. Boehncke +6 more
2020Arthritis care & research17 citations Open access
Semantic Scholar
Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo‐Controlled DISCOVER‐1 Study
C. Ritchlin, A. Deodhar, W. Boehncke, E. Soriano +7 more
2023ACR Open Rheumatology16 citations Open access
Semantic Scholar
Multi-omics analysis identifies IgG2b class-switching with ALCAM-CD6 co-stimulation in joint-draining lymph nodes during advanced inflammatory-erosive arthritis
H. Kenney, J. Rangel-Moreno, Yue Peng, Kiana L Chen +15 more
2023Frontiers in Immunology14 citations Open access
Semantic Scholar
Aiming for Cure and Preventive Initiatives in Psoriatic Disease: Building Synergy at NPF, GRAPPA, and PPACMAN
S. Bell, J. Merola, D. Webster, S. Pennington +5 more
2020Current Rheumatology Reports14 citations
Semantic Scholar
IL-23 induces CLEC5A+ IL-17A+ neutrophils and elicit skin inflammation associated with psoriatic arthritis
H. Furuya, Cuong Thach Nguyen, T. Chan, A. Marusina +8 more
2024Journal of Autoimmunity13 citations Open access
Semantic Scholar
Persistent popliteal lymphatic muscle cell coverage defects despite amelioration of arthritis and recovery of popliteal lymphatic vessel function in TNF-Tg mice following anti-TNF therapy
H. Kenney, Yue Peng, Richard D. Bell, R. Wood +3 more
2022Scientific Reports13 citations Open access
Semantic Scholar
Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritis
L. Coates, C. Ritchlin, L. Gossec, P. Helliwell +11 more
2022Rheumatology13 citations Open access
Semantic Scholar
New onset of axial spondyloarthropathy in patients treated with isotretinoin for acne vulgaris: incidence, follow-up, and MRI findings
B. Elnady, T. Elkhouly, Noha M. Dawoud, D. Desouky +3 more
2020Clinical Rheumatology13 citations
Semantic Scholar
Distinct mast cell subpopulations within and around lymphatic vessels regulate lymph flow and progression of inflammatory-erosive arthritis in TNF-transgenic mice
Yue Peng, H. Kenney, K. L. de Mesy Bentley, Lian-Ping Xing +2 more
2023Frontiers in Immunology11 citations Open access
Semantic Scholar
Moving the Goalpost Toward Remission: The Case for Combination Immunomodulatory Therapies in Psoriatic Arthritis
J. Scher, A. Ogdie, J. Merola, C. Ritchlin
2021Arthritis & Rheumatology11 citations
Semantic Scholar
The effect of guselkumab on inhibiting radiographic progression in patients with active psoriatic arthritis: study protocol for APEX, a Phase 3b, multicenter, randomized, double-blind, placebo-controlled trial
C. Ritchlin, L. Coates, P. Mease, D. M. van der Heijde +5 more
2023Trials10 citations Open access
Semantic Scholar
Implementation of automated behavior metrics to evaluate voluntary wheel running effects on inflammatory-erosive arthritis and interstitial lung disease in TNF-Tg mice
H. Kenney, R. Wood, Gabriel Ramirez, Richard D. Bell +8 more
2023Arthritis Research & Therapy10 citations Open access
Semantic Scholar
Dendritic cell-specific transmembrane protein is required for synovitis and bone resorption in inflammatory arthritis
Maria de la Luz Garcia-Hernandez, J. Rangel-Moreno, M. García-Castañeda, H. Kenney +6 more
2022Frontiers in Immunology9 citations Open access
Semantic Scholar
Tofacitinib in Patients With Psoriatic Arthritis and Metabolic Syndrome: A Post hoc Analysis of Phase 3 Studies
C. Ritchlin, J. Giles, A. Ogdie, J. Gómez-Reino +7 more
2020ACR Open Rheumatology9 citations Open access
Semantic Scholar
Navigating the diverse immune landscapes of psoriatic arthritis
C. Ritchlin
2021Seminars in Immunopathology8 citations
Semantic Scholar
Expert Perspective: Management of the Psoriatic Arthritis Patient After Failure of One Tumor Necrosis Factor Inhibitor
Ying-Ying Leung, A. Kavanaugh, C. Ritchlin
2023Arthritis & Rheumatology7 citations Open access
Semantic Scholar
Guselkumab, a Selective Interleukin‐23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies
D. McGonagle, I. McInnes, A. Deodhar, G. Schett +9 more
2023ACR Open Rheumatology7 citations Open access
Semantic Scholar
SAT0403 EFFICACY AND SAFETY OF 108 WEEKS’ BIMEKIZUMAB TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS: INTERIM RESULTS FROM A PHASE 2 OPEN-LABEL EXTENSION STUDY
I. McInnes, J. Merola, P. Mease, L. Coates +4 more
20207 citations Open access
Semantic Scholar
Guselkumab Modulates Differentially Expressed Genes in Blood of Patients With Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo‐Controlled Trials
S. Siebert, K. Sweet, C. Ritchlin, E. Hsia +7 more
2023ACR Open Rheumatology6 citations Open access
Semantic Scholar
POS0231 SUSTAINED EFFICACY AND SAFETY OF BIMEKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO TUMOUR NECROSIS FACTOR INHIBITORS: RESULTS FROM THE PHASE 3 BE COMPLETE STUDY AND ITS OPEN-LABEL EXTENSION UP TO 1 YEAR
L. Coates, R. Landewé, I. Mcinnes, P. Mease +12 more
2023Annals of the Rheumatic Diseases5 citations Open access
Semantic Scholar
The Enigmas of Lymphatic Muscle Cells: Where Do They Come From, How Are They Maintained, and Can They Regenerate?
E. Schwarz, H. Kenney, Yue Peng, K. L. de Mesy Bentley +2 more
2023Current Rheumatology Reviews5 citations Open access
Semantic Scholar
Meaningful Improvement in General Health Outcomes with Guselkumab Treatment for Psoriatic Arthritis: Patient-Reported Outcomes Measurement Information System-29 Results from a Phase 3 Study
A. Orbai, L. Coates, A. Deodhar, P. Helliwell +9 more
2022Patient5 citations Open access
Semantic Scholar
Proceedings of the 2019 GRAPPA Collaborative Research Network Meeting
R. Waxman, C. Stober, D. Jadon, A. Orbai +12 more
2020Journal of Rheumatology Supplement5 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Mease×14
Invite
P. Mease — researcher profile on SciRah
J. Merola×14
Invite
J. Merola — researcher profile on SciRah
I. McInnes×13
Invite
I. McInnes — researcher profile on SciRah
A. Kollmeier×10
Invite
A. Kollmeier — researcher profile on SciRah

×10

Invite

Xie L. Xu — researcher profile on SciRah

Invite

L. Coates — researcher profile on SciRah

P. Helliwell×9

Invite

P. Helliwell — researcher profile on SciRah

Invite

S. Sheng — researcher profile on SciRah

Invite

M. Shawi — researcher profile on SciRah

Invite

A. Deodhar — researcher profile on SciRah

Invite

A. Ogdie — researcher profile on SciRah

Invite

H. Kenney — researcher profile on SciRah